SCAN™ (Assessment Form)

The first step to Larta’s accelerator services

Address commercialization goals by developing an action plan for Commercialization Assistance Programs (CAP)

SCAN™ is a strategic product that provides fundamental business research and consulting services to help companies assess their current versus desired state for technological products, processes, or solutions. The assessment form covers a wide range of crucial business needs, including market positioning, market gap analysis, market attractiveness analysis, market strength analysis, regulatory approvals analysis, analysis of the viability of business models, market competitiveness analysis, intellectual property assessments, sales strategies, management team developments, strategic partnership developments, business funding strategies, and business financial plans.

Through SCAN™, companies can access expert consultation services and business assessment tools that are specifically designed for the technology sector. The goal is to help companies identify solutions to address market gaps for technologies, evaluate their intended market, assess the current state of their business, and select the best teaming arrangements with partners who have experience and capabilities across a range of areas.

SCAN™ Assessment

SCAN™ Assessment:

• Market Readiness

• Intellectual Property

• Management and Project Infrastructure

• Financials

• Meeting schedule and next steps

• SWOT Analysis

Sections:

Section 1: Company and Project Overview

Section 2: SWOT Analysis

Section 3: Market Readiness

Section 4: Intellectual Property

Section 5: Management/Project Infrastructure

Section 6: Financials

Section 7: CAP Program Participation

Section 8: Meeting Schedule and Next Steps

Keep in Mind:

1: Some sections will be pre-completed based on your Intake Form

2: Add your insights in the “Company Comments” Section

3: Some sections do NOT allow company responses as those are intended to be completed by your Principal Advisor

4: Fill out company related sections in advance to guide your discussion with your PA

5: SCAN is considered complete once the PA submits

Larta-Products-SCAN-Assesment-Preview-02Larta-Products-SCAN-Assesment-Preview-02
Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Product Marketing Description

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. 

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Our team of 125+ expert Mentors & Principal Advisors.

Our programs & products are led by seasoned industry experts with deep sector knowledge. Each startup is assigned a dedicated Principal Advisor to guide their journey from idea to sustainable enterprise.

Larta-PA-Kwame-Ulmer-01
Principal Advisor

Kwame Ulmer

Kwame Ulmer brings 20+ years of experience evaluating medical technologies in the government and serving in senior operating roles at medical device companies.
Sydney Edwards
Principal Advisor

Sydney Edwards

Executive experience working with startups on product and strategy development and incrasing portfolio values in the Biotech and Life Science Industry
LeAnne C. Tourtellotte-01
Principal Advisor

LeAnne C. Tourtellotte

CEO and Co-Founder of JL Biosciences, experience in IP management, business development, strartup management, and commercializing technology in startups
Larta-PA-Sunil-Maulik-01
Principal Advisor

Sunil Maulik

Sunil has held management positions at Pangea Systems, Tripos (NASDAQ:TRPS), Hoffmann-La Roche (NYSE: ROCHE), Oxford Molecular (LSE: OXMOL), and IntelliGenetics.

Browse & apply to join our open programs, including commercialization accelerator & assistance programs for SBIR/STTR government grant awardees, and private startup accelerators supported by our ecosystem of partners.

Commercialization Assistance Program (NOAA-CAP)

Commercialization Assistance Program (CAP) – for DOE SBIR Phase I Grant Awardees

Commercialization Assistance Program (CAP) – for DOE SBIR Phase II Grant Awardees

Technical & Business Assistance (TABA) – for SBIR Phase I and II Awardees

Scroll to Top